Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore effective ways to earn money with side jobs now. Choose options that fit your lifestyle and start today.
22,363 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A new State of AI report finds openai’s lead over other AI labs has largely faded as competitors close the gap, resha...
Micron Here! signals a moment of real opportunity for memory-chip investors who want clarity. This guide breaks down ...
The Dow’s first-half drama centered on one tech mega-cap that stood out for all the wrong reasons. This article break...
The strait hormuz back under renewed conflict tests oil bulls and hedges. Markets brace for higher volatility as crud...
Oklo just dropped below $50, sparking questions about long-term value. This guide breaks down what to check, how to a...
As U.S.–Iran tensions flare, energy prices surge and corporate boards adjust risk, liquidity and strategy in a newly ...
Ron Paul challenges President Trump’s move to hold government stakes in private companies, arguing it threatens liber...
SpaceX hovers around $135 ahead of a pivotal Starship test. This report weighs the case for spacex $135: should space...
Retirees approaching 65 must act within a six-month window to secure guaranteed Medigap pricing. Missing the medigap ...
A retiree discovered that a severance-heavy last paycheck can trigger a Medicare surcharge years later. This story ex...
In a bold move amid 13F season, investor Gavin Baker places a major levered bet on Nvidia through call options, signa...